Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Autor: Reginster, J-Y., Adami, S., Lakatos, P., Greenwald, M., Stepan, J. J., Silverman,, S. L., Christiansen, C., Rowell, L., Mairon, N., Bonvoisin, B., Drezner, M. K., Emkey, R., Felsenberg,, D., Cooper, C., Delmas, P. D., Miller, P. D.
Zdroj: Annals of the Rheumatic Diseases; May2006, p654-661, 8p
Databáze: Complementary Index